"范德瑞"潘多星五合一疫苗 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"范德瑞"潘多星五合一疫苗

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - diphtheria toxoid;;tetanus toxoid;;pertussis bordetella;;pertussis toxoid;;filamentous haemagglutinin;;inactivated poliovirus vaccine type i;;inactivated poliovirus vaccine type ii;;inactivated poliovirus vaccine type iii;;polysaccharide of haemophilus influenzae type b;;conjugated to the tetanus protein - 凍晶注射劑及懸浮注射液 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) diphtheria toxoid….……≧30 iuiu; tetanus toxoid (8008000200) tetanus toxoid..……………≧40 iuiu; conjugated to the tetanus protein (8008000230) 18-30ugug; pertussis bordetella (8012000110) bordetella pertussis antigens; inactivated poliovirus vaccine type i (8012002201) type 1 poliovirus (inactivated)du; inactivated poliovirus vaccine type ii (8012002202) type 2 poliovirus (inactivated)du; inactivated poliovirus vaccine type iii (8012002203) type 3 poliovirus (inactivated)du; polysaccharide of haemophilus influenzae type b (8012020000) ug; filamentous haemagglutinin (9200050300) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus - 適用於出生2個月至7歲孩童的主動免疫接種,以預防白喉、破傷風、百日咳、小兒麻痺及侵襲性b型嗜血桿菌疾病。

安律平新型流感疫苗 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

安律平新型流感疫苗

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - a/california/7/2009(h1n1)v-like virus;;squalene;;tocopherol alpha dl- (eq to dl-alpha tocopherol);;tween 80 (eq to polysorbate 80) - 懸浮注射劑 - a/california/7/2009(h1n1)v-like virus (8012002473) ug ha; tocopherol alpha dl- (eq to dl-alpha tocopherol) (8820000113) mg; tween 80 (eq to polysorbate 80) (9600023580) mg; squalene (9600030000) mg - influenza, inactivated, split virus or surface antigen - 預防新型流感。

潘多星五合一疫苗 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

潘多星五合一疫苗

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - diphtheria toxoid;;tetanus toxoid;;pertussis bordetella;;pertussis toxoid;;filamentous haemagglutinin;;inactivated poliovirus vaccine type i;;inactivated poliovirus vaccine type ii;;inactivated poliovirus vaccine type iii;;polysaccharide of haemophilus influenzae type b;;conjugated to the tetanus protein - 凍晶注射劑及懸浮注射液 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) diphtheria toxoid….……≧30 iuiu; tetanus toxoid (8008000200) tetanus toxoid..……………≧40 iuiu; conjugated to the tetanus protein (8008000230) 18-30ugug; pertussis bordetella (8012000110) bordetella pertussis antigens; inactivated poliovirus vaccine type i (8012002201) type 1 poliovirus (inactivated)du; inactivated poliovirus vaccine type ii (8012002202) type 2 poliovirus (inactivated)du; inactivated poliovirus vaccine type iii (8012002203) type 3 poliovirus (inactivated)du; polysaccharide of haemophilus influenzae type b (8012020000) ug; filamentous haemagglutinin (9200050300) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus - 適用於出生2個月至7歲孩童的主動免疫接種,以預防白喉、破傷風、百日咳、小兒麻痺及侵襲性b型嗜血桿菌疾病。

輔流威適流感疫苗 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

輔流威適流感疫苗

台灣東洋藥品工業股份有限公司 台北市南港區園區街3之1號3樓 (11821341) - a/wisconsin/67/2022 (h1n1) pdm09 - like virus (a/georgia/12/2022 cvr-167);;a/darwin/6/2021 (h3n2) - like virus (a/darwin/11/2021);;b/austria/1359417/2021 - like virus (b/singapore/wuh4618/2021);;b/singapore/inftt-16-0610/2016 (a b/phuket/3073/2013-like virus) - 懸浮注射劑 - 主成分 (composition of flucelvax quad for nh2019/2020 influenza season (quantity per dose)) ; b/singapore/inftt-16-0610/2016 (a b/phuket/3073/2013-like virus) (8012002484) ug ha; b/austria/1359417/2021 - like virus (b/singapore/wuh4618/2021) (8012006285) ug ha; a/wisconsin/67/2022 (h1n1) pdm09 - like virus (a/georgia/12/2022 cvr-167) (8012018042) ug ha; a/darwin/6/2021 (h3n2) - like virus (a/darwin/11/2021) (8012018051) ug ha - influenza, inactivated, split virus or surface antigen - 適用於6個月以上兒童及成人之主動免疫接種,預防此疫苗所涵蓋之兩種a型及兩種b型流感病毒所引起的流感相關疾病。

祈萊亞靜脈輸注用懸浮液 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

祈萊亞靜脈輸注用懸浮液

台灣諾華股份有限公司 臺北市中山區民生東路3段2號8樓 (01516589) - tisagenlecleucel (ctl019 cells) - 注射劑 - tisagenlecleucel (ctl019 cells) (1000000500) 1.2 x 10^6 to 6.0 x 10^8 car-positive viable t cellsq.s. - tisagenlecleucel - 經過基因修飾的自體免疫細胞療法,適用於治療:•患有難治型、移植後復發、第二次或二次以上復發之b細胞急性淋巴性白血病(all)的25歲以下兒童和年輕成人病人。•經兩線或兩線以上全身治療後之復發性或難治性瀰漫性大b細胞淋巴瘤(dlbcl)的成人病人。•經兩線或兩線以上全身治療後之復發性或難治性濾泡性淋巴瘤(fl)成人病人。

威特糖漿 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

威特糖漿

大用股份有限公司 台北巿松山區南京東路五段356號13樓之1 (12319115) - vitamin a palmitate in oily solution;;ergocalciferol (vit d2calciferol);;riboflavin(5-phosphate sodium);;niacinamide (nicotinamide);;thiamine hydrochloride;;ascorbic acid (vit c);;cyanocobalamin (vit b12) - 糖漿劑 - vitamin a palmitate in oily solution (8804000302) (0.8mg) 800iu (i; niacinamide (nicotinamide) (8810000300) 2mg; thiamine hydrochloride (8810100900) 0.3mg; riboflavin(5-phosphate sodium) (8810209700) 0.341mg; cyanocobalamin (vit b12) (8811200300) 2mcg; ascorbic acid (vit c) (8816000100) 10mg; ergocalciferol (vit d2calciferol) (8818000200) (0.002mg) 80iu (i - 多種維生素缺乏症

威持糖漿 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

威持糖漿

大統貿易股份有限公司 台北巿南京東路五段188號6樓 (04706198) - vitamin a palmitate in oily solution;;ergocalciferol (vit d2calciferol);;riboflavin(5-phosphate sodium);;niacinamide (nicotinamide);;thiamine hydrochloride;;ascorbic acid (vit c);;cyanocobalamin (vit b12) - 糖漿劑 - vitamin a palmitate in oily solution (8804000302) (0.8mg) 800iu (i; niacinamide (nicotinamide) (8810000300) 2mg; thiamine hydrochloride (8810100900) 0.3mg; riboflavin(5-phosphate sodium) (8810209700) (0.341mg) 0.24mg; cyanocobalamin (vit b12) (8811200300) 2mcg; ascorbic acid (vit c) (8816000100) 10mg; ergocalciferol (vit d2calciferol) (8818000200) (0.002mg) 80iu (i - 多種維生素缺乏症

西那吉斯凍晶注射劑 50 毫克 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

西那吉斯凍晶注射劑 50 毫克

瑞士商艾伯維藥品有限公司台灣分公司 台北市中山區民生東路三段49號及51號15樓 (53653958) - palivizumab - 凍晶注射劑 - palivizumab (1013002200) mg - palivizumab - palivizumab 可作用於rsv 疾病高危險群之幼兒病患,包括支氣管肺發育不全(bpd)嬰兒、早產兒(小於或等於35妊娠週),及患有血液動力學上顯著之先天性心臟病(chd)幼兒族群,預防因rsv感染所引起之嚴重下呼吸道疾病。

西那吉斯凍晶注射劑 100 毫克 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

西那吉斯凍晶注射劑 100 毫克

瑞士商艾伯維藥品有限公司台灣分公司 台北市中山區民生東路三段49號及51號15樓 (53653958) - palivizumab - 凍晶注射劑 - palivizumab (1013002200) mg - palivizumab - palivizumab 可作用於rsv 疾病高危險群之幼兒病患,包括支氣管肺發育不全(bpd)嬰兒、早產兒(小於或等於35妊娠週),及患有血液動力學上顯著之先天性心臟病(chd)幼兒族群,預防因rsv感染所引起之嚴重下呼吸道疾病。